Comprehensive historical analysis of global market for  Perfusion Imaging has thoroughly analyzed in this report. It offers data and insights from 2019-2022, and provides extensive market forecasts from 2023-2032 by region/country and subsectors. It covers the price, sales volume, revenue, historical growth, gross margin, and future outlooks for the  Perfusion Imaging market.

The global perfusion imaging market size was worth around USD 2503.7 million in 2025 and is predicted to grow to around USD 3692.5 million by 2035 with a compound annual growth rate (CAGR) of 3.6% from 2026 to 2035. 

The report includes growth prospects in the global  Perfusion Imaging market by type, application, sub segement and region and QMI has compiled a comprehensive detailed research report to offer insights. The report details consumption in the Healthcare and other sectors. Regional coverage spans North America, Europe, and rest of the world including Asia Pacific.

Leading players of  Perfusion Imaging including:

• Siemens Healthineers AG
• GE HealthCare
• Canon Medical Systems Corporation
• Koninklijke Philips N.V.
• Lantheus Medical Imaging, Inc.
• Bracco Imaging S.p.A.
• Perimed AB
• Shimadzu Corporation
• Medtronic plc
• Toshiba Medical System
• Getinge AB
• Neusoft Corporation
• Terumo Corporation
• Apollo Medical Imaging Technology
• Others

Request To Download Free Sample copy of the report @ https://www.sphericalinsights.com/request-sample/19474

Market split by Segement, can be divided into:

 By Modality Type

• Single Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT)
• Doppler Echocardiography

By Application

• Coronary Artery Disease (CAD)
• Myocardial Infarction (MI)
• Cardiomyopathy
• Epilepsy
• Dementia
• Transplant Evaluation
• Brain Trauma
• Pulmonary Embolism (PE)
• Osteonecrosis
• Other Applications

 Market segment by Region/Country including:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

Check discount for this report: https://www.sphericalinsights.com/request-discount/19474

In March 2026, Lantheus Holdings received FDA approves PYLARIFY TruVu (piflufolastat F 18) for PET imaging of PSMA-positive prostate cancer lesions. The new formulation enhances stability, supports larger batch production, expands patient access, and improves distribution efficiency, leveraging prior pivotal studies OSPREY and CONDOR for safety and effectiveness.

In December 2025, 4DMedical expands its CT: VQ distribution with Philips in North America, targeting US$10 million in orders for 2026-2027. The FDA-cleared, non-contrast CT ventilation-perfusion solution enables quantitative lung imaging without radiotracers, integrating seamlessly with existing CT infrastructure to improve access, workflow, and diagnostic precision.

In November 2025, Nicolab received FDA 510(k) clearance for its StrokeViewer LVO Triaging and CT Perfusion algorithms. The AI-powered platform rapidly detects large vessel occlusions and generates perfusion maps, enabling timely stroke diagnosis and treatment. Supported by a 384-patient study, the technology enhances clinical decision-making and accelerates life-saving care.

In May 2025, Lantheus Holdings: Lantheus sells its SPECT business, including TechneLite, NEUROLITE, Xenon Xe-133, and Cardiolite, to SHINE Technologies. The deal allows Lantheus to focus on PET radiodiagnostics and microbubbles, while SHINE ensures continued production, expansion, and innovation in nuclear medicine and SPECT operations.

In March 2025, Bracco launches HeartSee v4.0, enhancing myocardial blood flow quantification for cardiac PET imaging. Updates include subendocardial ischemia measurement, relative stress flow, and ejection fraction analysis, broadening access, improving usability, and supporting more precise coronary artery disease diagnosis and treatment across hospitals and clinics.

In September 2024, GE HealthCare’s Flyrcado (flurpiridaz F 18) receives FDA approval as the first PET myocardial perfusion imaging agent for coronary artery disease. Offering higher diagnostic accuracy than SPECT, a long half-life enables wider distribution, exercise stress testing, and rescans, improving access and imaging efficiency for patients, including high-BMI individuals and women.

Access full Report with Table of Content @ https://www.sphericalinsights.com/reports/perfusion-imaging-market

Whats covered in the report?

• 1. Overview of the  Perfusion Imaging market.
• 2. The current and forecasted regional (North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa) market size data for the  Perfusion Imaging market, based on segement.
• 3.  Perfusion Imaging Market trends.
• 4.  Perfusion Imaging Market drivers.
• 5. Analysis of major company profiles.

Reasons to buy this Market Report:

1. Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging  Perfusion Imaging market.

2. Use the SWOT analysis to determine the competitive intensity and therefore attractiveness of the emerging  Perfusion Imaging Industry.

3. Leading company profiles reveal details of key  Perfusion Imaging market players emerging five operations and financial performance.

4. Add weight to presentations and pitches by understanding the future growth prospects of the emerging  Perfusion Imaging market with five year historical forecasts.

5. Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region.

6. Extensive information on factors that will amplify the growth of the  Perfusion Imaging market over the upcoming seven years

7. Accurate estimation of the global  Perfusion Imaging market size

8. Exact estimations of the upcoming trends and changes observed in the consumer behavior

9. Growth of the global  Perfusion Imaging market across the North & South America, EMEA, Asia Pacific, and Latin America

10. Information about  Perfusion Imaging market growth potential

11. In-depth analysis of the industry’s competitive landscape and detailed information vis-a-vis on various vendors

12. Furnishing of detailed information on the factors that will restrain the growth of the  Perfusion Imaging market

About the Spherical Insights

Spherical Insights is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.

which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.

Contact Us:

Company Name: Spherical Insights

Email: sales@sphericalinsights.com

Phone: +1 303 800 4326 (US)

Follow Us: LinkedIn | Facebook | Twitter